InspireMD, Inc. Warrants
NSPRW
NSPRW was delisted on the 7th of July, 2021.
1 hedge funds and large institutions have $1K invested in InspireMD, Inc. Warrants in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
50% less capital invested
Capital invested by funds: $2K → $1K (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1K |
NSPRW Hedge Fund Activity: Q2 2019 in Review
1 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Warrants (NSPRW) for Q2 2019, worth a combined $1K — down 50% from $2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NSPRW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $2. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1K sold.
- 1 institutional investor held InspireMD, Inc. Warrants (NSPRW) as of Q2 2019, down from 2 in Q1 2019.
- Funds reported $1K of InspireMD, Inc. Warrants stock for Q2 2019, down 50% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Warrants positions in Q2 2019 and 1 closed out, a net change of -1 holder.
- The largest InspireMD, Inc. Warrants buyer in Q2 2019 was UBS Group, an estimated $2 added.
- The largest InspireMD, Inc. Warrants seller in Q2 2019 was Susquehanna International Group, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2019.